{"nct_id":"NCT04524273","title":"Myasthenia Gravis Inebilizumab Trial","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-02","start_date":"2020-10-15","start_date_type":"ACTUAL","primary_completion_date":"2024-05-28","primary_completion_date_type":"ACTUAL","completion_date":"2027-11-29","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AMGN"]}